J&J gets out of diagnostics

Share this article:

Johnson & Johnson is offloading its Ortho Diagnostics business for $4 billion. The company announced Monday that it accepted the Carlyle Group's January offer to take on the business, which includes in-vitro diagnostic products.

Bloomberg reports that Carlyle expects to run the unit as a standalone business, and that the transaction relieves J&J of its only diagnostics division.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters